IP Library Patent Application 14275752
Patent Application
App. No. 14/275,752

Methods, Systems And Compositions Related To Reduction Of Conversions Of Microbially Produced 3-Hydroxypropionic Acid (3-HP) To Aldehyde Metabolites

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/275,752
Abstract

The present invention relates to methods, systems and compositions, including genetically modified microorganisms, directed to achieve decreased microbial conversion of 3-hydroxypropionic acid (3-HP) to aldehydes of 3-HP. In various embodiments this is achieved by disruption of particular aldehyde dehydrogenase genes, including multiple gene deletions. Among the specific nucleic acids that are deleted whereby the desired decreased conversion is achieved are aldA, aldB, puuC), and usg of E. coli . Genetically modified microorganisms so modified are adapted to produce 3-HP, such as by approaches described herein.

Claims (24)

1 - 158 . (canceled)

159 . A genetically modified microorganism comprising:

a. a deletion of aldA, aldB, and puuC; and

b. a genetic modification of mcr.

160 . The genetically modified microorganism of claim 159 , further comprising a deletion of a gene selected from the group consisting of betB, eutE, eutG, fucO, gabD, garR, gldA, glxR, gnd, ldhA, maoC, proA, putA, sad/ynel, ssuD, ybdH, ygbJ, and yiaY.

161 . The genetically modified microorganism of claim 160 , wherein the gene is ldhA.

162 . The genetically modified microorganism of claim 159 , further comprising a deletion of usg.

163 . The genetically modified microorganism of claim 159 , wherein enzymatic conversion of 3-hydropropionic acid (3-HP) to an aldehyde of 3-HP is reduced compared to a control microorganism.

164 . The genetically modified microorganism of claim 163 , wherein the aldehyde is selected from the group consisting of 3-hydroxypropionaldehyde, malonate semialdehyde, malonate, and malonate di-aldehyde.

165 . The genetically modified microorganism of claim 163 , wherein the enzymatic conversion of 3-HP to an aldehyde is decreased by at least 5%, 10%, 20%, 30%, or at least 50% of the enzymatic conversion of 3-HP to an aldehyde by a control microorganism.

166 . The genetically modified microorganism of claim 159 , wherein production of 3-HP is increased when compared to a control microorganism.

167 . The genetically modified microorganism of claim 166 , wherein the production of 3-HP is increased by at least 5%, 10,% or 20% when compared to a control microorganism.

168 . The genetically modified microorganism of claim 159 , wherein the genetic modification of mcr comprises a vector, wherein the vector comprises at least one heterologous nucleic acid molecule which encodes the protein sequence of malonyl-coA reductase.

169 . The genetically modified microorganism of claim 159 , wherein the genetically modified microorganism is a gram-negative bacterium.

170 . The genetically modified microorganism of claim 159 , wherein the genetically modified microorganism is selected from the genera: Zymomonas, Escherichia, Pseudomonas, Alcaligenes, Salmonella, Shigella, Burkholderia, Oligotrophoa , and Klebsiella.

171 . The genetically modified microorganism of 159 , wherein the genetically modified microorganism is selected from the species: Escherichia coli, Cupriavidus necator, Oligotropha carboxidovorans , and Pseudomonas putida.

172 . The genetically modified microorganism of 159 , wherein the genetically modified microorganism is an E. coli strain.

173 . The genetically modified microorganism of 159 , wherein the genetically modified microorganism is a gram-positive bacterium.

174 . The genetically modified microorganism of 159 , wherein the genetically modified microorganism is selected from the genera Clostridium, Rhodococcus, Bacillus, Lactobacillus, Enterococcus, Paenibacillus, Arthrobacter, Corynebacterium , and Brevibacterium.

175 . The genetically modified microorganism of 159 , wherein the genetically modified microorganism is selected from the species: Bacillus licheniformis, Paenibacillus macerans, Rhodococcus erythropolis, Lactobacillus planatarum, Enterococcus faecium, Enterococcus gallinarium, Enterococcus faecalis , and Bacillus subtilis.

176 . The genetically modified microorganism of 159 , wherein the genetically modified microorganism is B. subtilis.

177 . The genetically modified microorganism of 159 , wherein the genetically modified microorganism is a fungus or yeast.

178 . The genetically modified microorganism of 159 , wherein the genetically modified microorganism is selected from the genera Pichia, Candida, Hansenula , and Saccharomyces.

179 . The genetically modified microorganism of 159 , wherein the genetically modified microorganism is Saccharomyces cerevisiae.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Oct 12, 2016
From: SILICON VALLEY BANK
To: OPX BIOTECHNOLOGIES, INC.
Reel/Frame 040746/0051 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 16, 2015
From: OPX BIOTECHNOLOGIES, INC.
To: CARGILL, INCORPORATED
Reel/Frame 037312/0763 →
SECURITY INTEREST Recorded Apr 7, 2015
From: OPX BIOTECHNOLOGIES, INC.
To: SILICON VALLEY BANK
Reel/Frame 035350/0608 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 19, 2014
From: LYNCH, MICHAEL D.; MERCOGLIANO, CHRISTOPHER P.; LIPSCOMB, TANYA E.W.; LIPSCOMB, MATTHEW
To: OPX BIOTECHNOLOGIES, INC.
Reel/Frame 032926/0566 →